stem cells

News on iPS cells from some top scientists at ASGCT meeting today

There were three talks today on iPS cells here at the American Society for Gene and Cell Therapy meeting or ASGCT meeting in Seattle. Dr. James Ellis made the interesting case that it may be preferable to make iPS cells using genetic methods (while everyone else seems to be saying that non-genetic methods will be better).

News on iPS cells from some top scientists at ASGCT meeting today Read More »

Why invest in stem cells? Progress, Patients, and Patents

Why invest in stem cells? Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of

Why invest in stem cells? Progress, Patients, and Patents Read More »

Why miRNA iPS cells might be the ticket: an A+ paper

Since Yamanaka’s discovery of iPS cells first in mouse and then in human cells 5 years ago, both made using viral transduction, a host of new methods to make iPS cells have been reported.  These methods are quite diverse, ranging from transposons, to recombinant proteins, to plasmids, and to RNA.  Often times these new approaches

Why miRNA iPS cells might be the ticket: an A+ paper Read More »

Roman Reed Act is funded! A great day for spinal cord injury research!

The California Public Safety Committee today passed AB 190 and in so doing has funded the Roman Reed Spinal Cord Injury Research Act! The action will provide up to $11 million a year in funding for spinal cord injury research. This is amazing news and is the result of a lot of hard work by

Roman Reed Act is funded! A great day for spinal cord injury research! Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.